YB
Yubo International Biotech Limited
YBGJ · OTC
$0.01 +0.00% (+$0.00)
1M -24.23%
Market Cap $1.84M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 13.70x
P/E N/A
EV/EBITDA N/A
Growth
37 /100
Stable EPS growth 8.30%
Rev. growth 3.64%
Book val. growth 0.91%
Profitability
10 /100
Weak Gross margin 28.01%
Net margin 694.87%
FCF margin 275.73%
Quality
61 /100
Average ROIC 32.28%
ROA 138.91%
Asset turnover 0.20x
Debt
0 /100
High Current ratio 0.18x
Int. coverage -163.81x
Debt/Equity N/A
Stability
99 /100
Stable Beta 0.71x
Rev. volatility 3.46%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o YBGJ
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Yang Wang
Employees
14
Headquarters
Beijing